Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy

  • Interventional
  • Recruiting
  • NCT03585660
Eligibility Details Visit Clinicaltrials.gov

MRI Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

The purpose of the proposed research is to test and validate an artificial intelligence-based Risk Map decision-support system (DSS) for prostate cancer Magnetic Resonance Imaging (MRI) interpretation and identification of clinically significant tumor site(s).

Gender
Male

Age Group
18 Years and up

Accepting Healthy Volunteers?
No

Inclusion Criteria:

         - Patients with known or suspected prostate cancer who have been referred to the Department of Radiology at the University of Chicago Medical Center for a diagnostic MRI exam of the prostate, to be followed by an MRI-guided fusion biopsy of the prostate.

         - Written informed consent.

        Exclusion Criteria:

         - Patients incapable of giving informed written consent;

         - Patients who cannot adhere to the experimental protocols for any reason, or have an inability to communicate with the researcher;

         - Patients with psychiatric disorders that affect their ability to consent for themselves will be excluded and not the entire population of patients with psychiatric disorders.

         - Prisoners;

         - Minor children (under the age of 18 years old).

At a Glance

National Government IDNCT03585660

IRB#IRB17-1694

Lead SponsorUniversity of Chicago

Lead PhysicianAytekin Oto

Collaborator(s)N/A

EligibilityMale
18 Years and up
Recruiting